We are delighted to announce that Lidings has updated The Pharma Legal Handbook: Russia - practical directory focused on the key aspects of legislative regulation of pharmaceutical industry in Russia.

Lidings law firm announces the acceptance of applications of the clients of WEX Crypto Exchange to consider the matter of the possibility of repayment of funds being earlier legally transferred for the crypto exchange for investment purposes.

Lidings takes high positions in the new rating of the leading legal advisors in Russia based on the analytical research held annually by the “Kommersant” newspaper. In 2024 the firm is ranked among the TOP leading legal advisors in Russia. 

Lidings is pleased to announce Natalya Thotahewage, a recognized expert in pharmaceuticals and healthcare, joining the firm as counsel and the appointment of Elizaveta Fursova, Head of the Lidings' Employment practice, as counsel.

In March 2024 Lidings partner Stepan Guzey visited the UAE (Dubai), Oman (Muscat), the Kingdom of Saudi Arabia (Riyadh) and Bahrain (Manama) during his regular business trip to the Middle East.

During the two-week visit Stepan held more than 25 business meetings with representatives of leading local law firms and government agencies to establish and strengthen partnerships, as well as discussed current and future projects with clients to whom Lidings provides comprehensive legal support for both outward and inward investment projects in the Middle East region.

Lidings Dispute Resolution practice team achieved recognition and enforcement of an arbitration award of the Federation of Oils, Seeds and Fats Associations (FOSFA) in favor of a major German food producer in a dispute against a Russian agricultural manufacturer.

On 7 December 2023 the results of the annual Pravo-300 law firms’ ranking were announced at an awarding ceremony at The Carlton Hotel in Moscow. This year Lidings expertise is highly praised in 15 key practice areas.

Lidings’ IP team has successfully secured recognition of the Doppelherz brand as a well-known trademark specifically for dietary supplements, setting a valuable precedent. The interests of the client, the German pharmaceutical company Queisser Pharma, which owns the brand, were represented by Boris Malakhov, Partner, and Vladislav Ryabov, Senior Associate.

Lidings' sanctions compliance and corporate & M&A practice lawyers managed the conversion of depositary receipts (ADRs) into stocks of a Russian issuer in support of private clients from Europe and the United States.